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Summary 
Trypanosoma brucei undergoes antigenic variation in 
the mammalian host. This can be achieved by activa- 
tion and inactivation of telomeric variant-specific 
surface glycoprotein genes (vsg). In procyclic (insect 
midgut stage) cells, Vsg is not expressed. The mecha- 
nisms that regulate transcription of vsg expression 
sites (ESs) are unknown. Here we demonstrate that 
transcription from three different promoters was re- 
pressed when they were inserted at a transcriptionally 
silent telomere-proximal locus in bloodstream-form 
cells. This position effect was stable and heritable. 
Only transcription from an ES promoter was repressed 
in procyclic cells. The observed position effect and the 
promoter-specific developmental regulation suggest 
that these phenomena reflect the mechanisms that 
regulate vsg expression. 
Introduction 
Trypanosoma brucei and related species are protozoan 
parasites responsible for diseases of cattle (Nagana) and 
humans (sleeping sickness) in Africa. The parasite is 
spread among mammalian hosts by Glossina, the tsetse 
fly. While in the blood and tissue spaces, T. brucei escapes 
elimination by the host immune system by undergoing 
antigenic variation (reviewed by Borst et al., 1993; Van- 
hamme and Pays, 1995). Individual bloodstream-form (BF) 
T. brucei cells apparently express a single variant-specific 
surface glycoprotein gene (vsg) at a time. The expressed 
vsg is invariably located adjacent to a telomere and is 
transcribed as part of a polycistronic transcription unit, 
with the promoter located usually -50 kb upstream. 
These transcription units are known as expression sites 
(ESs). The vsg genes located at silent ESs can be acti- 
vated in situ, concomitant with inactivation of the pre- 
viously active ES. 
When BFT. brucei are ingested by the tsetse, they differ- 
entiate into procyclic-form (PF) trypanosomes. PF cells no 
longer express Vsg but express another major surface 
glycoprotein, the procyclic acidic repetitive protein (Parp), 
also called procyclin (see Hehl and Roditi, 1994). PF cells 
are noninfective to the mammalian host. Whereas one ES 
is transcriptionally active in BF cells, many ES promoters 
are active at a reduced level in PF cells, where transcrip- 
tion is attenuated immediately downstream of the ES pro- 
moters (Rudenko et al., 1994). After migration of T. brucei 
to the tsetse salivary gland, differentiation to the meta- 
cyclic stage leads to reacquisition of mammalian infectivity 
and expression of a restricted subset of 1 O-l 5 vsg genes. 
About 5 days after entering the mammalian bloodstream, 
metacyclic Vsg is no longer detectable. 
In T. brucei clone 221a, vsg227 is expressed. In clone 
118a, the single copy of vsg227 is present at the same 
position but is not expressed. Regulation at this ES oc- 
curred with no major rearrangement up to 55 kb upstream 
of vsg227 (Bernards et al., 1984a) or with a single point 
mutation within 3.4 kb spanning the ES promoter (Zomer- 
dijk et al., 1990). We have used the vsg227 locus, in either 
active (clone 221 a) or silent (clone 118a) states, as a model 
to study ES regulation. We have measured transcription 
from three distinct T. brucei promoters at this locus in 
BF and PF T. brucei. RNA polymerase I is likely to be 
responsible for transcription from all three: ribosomal RNA 
(rRNA), Parp, and ES promoters (reviewed by Chung et 
al., 1992). 
Results 
The cassettes used in these experiments consisted of a 
promoter (rRNA, Parp, or an ES) flanked by two selectable 
genes (Figure 1). The upstream gene acts as a reporter 
for endogenous transcription running into the target locus. 
The promoter and downstream gene were included to se- 
lect for cells in which the cassette had integrated into an 
otherwise transcriptionally silent ES. If transcription from 
an upstream promoter is undetectable at the target locus, 
downstream reporter activity can be attributed to the inte- 
grated promoter. 
Expression of b/e and neo within an Actively 
Transcribed ES 
We first transformed 221a BF cells with pbRn, to confirm 
that the necessary signals for efficient bleomycin (b/e) and 
neomycin (neo) expression were present and that integra- 
tion at the intended position (see Figure 1) did not disrupt 
sequences necessary for vsg expression. The vsg227 lo- 
cus in 221a cells is transcribed from 60 kb upstream to 
beyond vsg227 (Johnson et al., 1987). Cloned trans- 
formants, designated 22l+/bRn BF cells, survived in con- 
centrations of G418 (selection for neo expression) and 
phleomycin (selection forble expression) at least 1 OOO-fold 
higher than those found to kill wild-type BF cells and con- 
tinued to express Vsg221, as determined by indirect immu- 
nofluorescence. 
Targeted Insertion into a Silent ES 
BF cells expressing Vsgl18 were transformed with pbRn, 
yielding G418-resistant cells, designated 118+/bRn, at a 
frequency similar to when the active vsg227 locus was 
targeted. Southern blot analysis of the transformants re- 
vealed incomplete digestion of DNA with Pstl, indicating 
DNA modification (Bernards et al., 1984b; Pays et al., 
1984) in vsg227 and the bRn cassette in 118+/bRn BF cells 
(Figure 2). The DNA modification responsible for inhibiting 
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Figure 1. Physical Maps Showing T. brucei Promoter Constructs and 
the vsg227 Locus 
(A) Boxes indicate regions shown to be important for activity of the 
rRNA (Janz and Clayton, 1994) Parp (Sherman et al., 1991; Brown 
et al., 1992) and ES (Vanhamme and Pays, 1995) promoters. Flags 
indicate the initiation sites (see Vanhamme and Pays, 1995) which 
are designated as position +l 
(B) pbRn is shown above the site of integration. The box with a flag 
indicates the promoter. The telomere is downstream of vsg227, and 
the endogenous ES promoter is Indicated by a flag. Splice acceptor 
(SA) sites are shown and x70 represents 70 bp repeat sequences. 
endonuclease activity is likely to be 8-o-glucosyl-hydroxy- 
methyluracil (Gommers-Ampt et al., 1993). Phosphorim- 
ager analysis of Southern blots indicated that - 10% of 
sites b-f were modified while <lo/o of site a was modified 
(Figure 2). 
Transcription from Three Independent T. brucei 
Promoters Is Repressed within the vsg221 ES 
in BF Cells Expressing Vsgl18 
To determine relative expression levels of the markers in 
the bRn cassette, we analyzed RNA and protein samples 
by Northern (Figure 3) and Western (data not shown) blot- 
ting. vsg227, neo, and b/e mRNA and protein were easily 
detectable in 221+/bRn BF cells. mRNA and protein from 
all three genes were very low or undetectable in 118+/ 
bRn BF cells. The 118+/bRn BF cells were shown to be 
expressing vsg778, and the filters were also hybridized 
with a tubulin (tub) probe as a loading control. Phosphorim- 
aging of the blots shown in Figure 3 indicated an -80-fold 
difference in neo expression between 221 +/bRn and 118’/ 
bRn BF cells. 
A growth inhibition assay was used as an independent 
measure of marker gene expression. The lCsO was defined 
as the inhibitory concentration of drug necessary to reduce 
the growth rate to 50%. 221 +/bRn BF cells gave lCsO values 
of 175 pg/ml for phleomycin and 1000 trglml for G418 
while 0.2 nglml phleomycin and 1 nglml G418 efficiently 
killed wild-type BF cells. 118+/bRn BF cells showed no 
resistance to phleomycin and gave an lCs0 of 13 rig/ml 
for G418. This assay indicated that neo expression was 
reduced 77-fold in a repressed ES relative to the active 
ES. b/e expression appeared to be >lOOO-fold lower in 
118+/bRn BF cells relative to 221+/bRn BF cells. These 
results confirmed that any transcription from the endoge- 
nous ES promoter was attenuated upstream of the b/e 
gene and showed that transcription from the rRNA pro- 
moter was repressed at the vsg227 locus in 118’lbRn BF 
cells. These observations were confirmed with a second 
independent clone. 
The rRNA promoter is a constitutive promoter. To inves- 
tigate the activity of two promoters for developmentally 
regulated genes at the silent vsg227 locus, we precisely 
replaced the fragment containing the rRNA promoter in 
pbRn with fragments containing the Parp or ES promoters, 
thus generating pbPn and pbEn, respectively (see Figure 
1A). BF cells expressing Vsgl18 were transformed with 
these constructs. Stable cloned transformants will be re- 
ferred to as 118’lbPn (integrated Parp promoter) and 118+/ 
bEn (integrated ES promoter). RNA (Figure 3) and protein 
(data not shown) analysis indicated that transcription from 
all three promoters was repressed at the vsg227 locus in 
BF cells expressing Vsg118. 
Only Transcription from the ES Promoter Remains 
Repressed in PF Ceils 
One advantage of transforming BF cells is that they can 
subsequently be differentiated to PF cells in culture (see 
1000 bp a b cde f 
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Figure 2. Physical Map of the vsg227 Locus after Integration of the 
pbfln Cassette 
(A) The probes used for Southern blot analysis are indicated as bars 
below the map. Six Pstl sites (a-f) are indicated at which partial diges- 
tion was seen by Southern blot analysis in (B). Relevant restriction 
sites are indicated: P, Pstl; S, Sall; Xb, Xbal; Xh, Xhol. 
(B) Southern blot analysis. Genomic DNA (3 pg) from wild-type 1 18a 
(lane I), 118+/bRn (lane 2), wild-type 221a (lane 3) and 221+/bRn BF 
(lane 4) cells were digested with the indicated restriction enzymes 
and separated in 0.8% agarose gels. Blots were hybridized with the 
indicated probes. Bands lettered a-f represent the products of partial 
digestion at the corresponding sites indicated in (A) (band a is undetect- 
able in this exposure). 
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Figure 3. Marker Expression Driven by Three Independent T. brucei 
Promoters in SF Cells 
RNA (1.5 wg) from wild-type 221 a (lane l), 221 +/bRn (lane 2) wild-type 
118a (lane 3), 118+/bRn (lane 4) 118+/bPn (lane 5) and 118+/bEn (lane 
6) cells was separated in 1% denaturing agarose gels. Blots were 
sequentially hybridized with the coding region probes indicated on the 
right of each panel. 
Overath et al., 1986). PF cultures were established from 
221+/b!% and 118+/bRn BF cells (in the absence of any 
drug) and were initially determined to be expressing par 
mRNA and Parp (see Hehl and Roditi, 1994). No Vsg118 
or Vsg221 was detected in these cultures by Western blot 
analysis (Figure 48; data not shown). The DNA modifica- 
tion found at telomeric loci in BF cells, exemplified by Pstl 
digestion, is absent from PF cells (Pays et al., 1984). 
Southern blot analysis with a vsg227 probe confirmed that 
DNA modification was no longer detectable in PF cells 
derived from 118’lbRn BF cells (data not shown). Regard- 
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Figure 4. Marker Expression Driven by an rRNA Promoter in PF Cells 
(A) RNA was isolated from 221+/bRn SF cells (lane 1; control), 221’1 
bRn PF cells (lane 2) and 118+/bRn PF cells (lane 3). The par coding 
region probe was derived from pd20-gem-4 (Mowatt and Clayton, 
1987). Other details are as in Figure 3. 
(5) Protein samples were isolated from the same cultures and sepa- 
rated in SDS-polyacrylamide gels. Lanes are as in (A). Slots were 
incubated with antibodies directed against the protein products of the 
gene indicated to the left of each panel. 
less of whether they were derived from 221 +/bRn or 118’1 
bRn BF cells, PF cells showed an identical pattern of neo 
and b/e expression (Figure 4). 
The b/e gene was flanked by actin (act) sequences, 
which allow constitutive expression in both life cycle 
stages (Hug et al., 1993). Lack of detectable b/e mRNA 
or Ble (the Streptoalloteichus hindustanus phleomycin re- 
sistance protein) showed that transcription from the en- 
dogenous ES promoter was attenuated in PF cells, as 
expected (Rudenko et al., 1994). The presence of high 
levels of neo mRNA and Neo (neo phosphotransferase) 
in both PF clones showed that transcription from the rRNA 
promoter was derepressed in 118+/bRn PF cells. The neo 
mRNA level in 221 +/bRn BF cells was 12-fold higher than 
in both PF types, when measured by phosphorimaging. 
The neo gene was flanked by aldolase (a/d) sequences. 
a/d mRNA is at least 6-fold less abundant in PF cells than 
in BF cells (Vijayasarathy et al., 1990), and this effect ap- 
pears to be mediated by the 3’ untranslated region (Hug 
et al., 1993). The difference between neo mRNA levels in 
221 +/bRn BF cells and 118’lbRn or 221 +/bRn PF cells may 
therefore be attributed to mRNA stability, processing dif- 
ferences, or both, mediated by the a/d 3’ untranslated re- 
gion. There were no measurable differences in Neo levels 
between PF cells and BF cells, however, suggesting differ- 
ences in translation efficiency or Neo stability between PF 
and BF cells. 
vsg227 mRNA was detectable in PF cells containing 
the rRNA promoter -2 kb upstream of the vsg227 splice 
acceptor (see Figure 1 A), but no protein was detectable 
(Figure 4). Phosphorimaging of a second Northern blot 
indicated that steady-state vsg227 mRNA in the PF try- 
panosome was - 10% of that found in BF cells expressing 
Vsg221, suggesting that the developmental regulation of 
Vsg expression includes translational or posttranslational 
controls (or both). 
PF cultures were also established from 118+/bPn and 
118+lbEn BF cells, containing the integrated Parp and ES 
PrOmOteE, respectively. Transcription from the Parp pro- 
moter was derepressed while transcription from the ES 
promoter remained repressed (Figure 5). Transcription 
from endogenous ES promoters is normally repressed 
after differentiation to PF cells, even when derived from 
the previously active state in BF cells (Rudenko et al., 
Neo 
46 
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Figure 5. Marker Expression Driven by Three Independent T. brucei 
Promoters in PF Cells 
Protein was isolated from 118+/bRn (lane I), 118+/bPn (lane 2), and 
118+/bEn (lane 3) PF cells and detected as in Figure 4. 
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1994). We were interested to see whether this was also 
the case for an ES promoter at the site of integration used 
in these experiments. 221a ceils were transformed with 
pbEn. These cells, designated 221+/bEn BF cells, exhib- 
ited the same high level resistance to G418 and phleo- 
mycin as did 221+/bRn BF cells. 2217bEn BF cells were 
differentiated to PF cells, and both developmental stages 
were analyzed by Western blotting (data not shown). Tran- 
scription from the inserted ES promoter, present in the 
previously active ES, was also repressed upon differentia- 
tion to PF cells. Because this was a negative result, we 
sequenced the 315 bp promoter element in the pbEn plas- 
mid and confirmed that it was unchanged from the se- 
quence used in transient transfection experiments (Zom- 
erdijk et al., 1990). We also showed that this 315 bp 
promoter sequence generates increased reporter gene 
expression at another chromosomal locus (unpublished 
data). 
The Stability of the Repressed State 
The rRNA, Parp, and ES promoters generated relatively 
low level expression of neo and vsg227 in the vsg227 locus 
in BF cells expressing Vsgl18. We wanted to know 
whether this was due to low level expression in all cells 
or high level expression in a subpopulation. Indirect immu- 
nofluorescence analysis of the 118+/bRn BF population 
revealed no cells expressing a detectable level of Vsg221, 
while >99% expressed Vsgl18. This suggested that tran- 
scription from the rRNA promoter was repressed in all of 
the cells. 
To examine larger numbers of cells in populations with 
transcription repressed from all three promoters, we took 
advantage of drug selection assays. Using previously de- 
termined IC5,, values as a guide, we selected cells from 
these populations that had become resistant to 50 uglml 
G418 or 2 uglml phleomycin. Resistant cells arose at a 
frequency of <10e6 in each of the three populations (118+/ 
bRn, 1 18+/bPn, and 1187bEn BF cells). Using phleo- 
mycin, we expected to select for cells in which transcrip- 
tion from the endogenous ES promoter was activated in 
situ or in which the cassette was duplicated or otherwise 
translocated downstream of a productive promoter. Using 
G418, we expected to select similar events and for the 
independent activation of transcription from the inserted 
promoter. The results indicated that transcription from all 
three promoters was repressed in the vast majority of cells 
and that all possible activation events occurred at a fre- 
quency of <10e6. The results also indicated that the re- 
pressed state is efficiently inherited. Cells that became 
resistant to either drug in these assays no longer ex- 
pressed Vsgl18 but expressed levels of Ble, Neo, and 
Vsg221 equivalent to 221+/bRn BF cells, indicating a 
switch to the 221 ES (unpublished data). 
We used a similar approach to determine the cellular 
status of low level b/e expression in 118+/bRn and 221+1 
bRn PF populations, which have an rRNA promoter driving 
neo expression, and the low level b/e and neo expression 
in 118+/bEn and 221+/bEn PF populations, which have a 
repressed ES promoter driving low level neo expression. 
A phleomycin concentration was determined to which PF 
cells derived from wild-type 118a or 221a BF cells were 
sensitive. Cells (1 06) of each clone were transferred into 
medium containing 20 uglml phleomycin. All four PF popu- 
lations (118+/bRn, 221+/bRn, 118+/bEn, and 221+/bEn) 
were killed within a few days, and no live cells were de- 
tected after 20 days, suggesting that any transcription 
from the endogenous ES promoter was efficiently sup- 
pressed in every cell. A G418 concentration was deter- 
mined to which 118’lbRn and 221+/bRn PF cells were re- 
sistant, while PF cells derived from wild-type 118a or 221 a 
BF cells were sensitive. Between 1 x IO6 and 5 x lo6 
118+/bEn or 221 ‘IbEn PF cells were transferred into me- 
dium containing 100 uglml G418. After 2 weeks, popula- 
tions of G418-resistant cells persisted in both cultures. By 
indirect immunofluorescence, we confirmed the presence 
of <0.5% of cells abundantly expressing Neo in the 118+/ 
bEn PF population, prior to drug selection. Selection of 
G418-resistant cells from two independent populations 
and detection of Neo-expressing cells prior to drug selec- 
tion suggest that marker gene expression is due to intrinsic 
heterogeneity within the population rather than to selec- 
tion of mutants. These results indicate that the inserted 
telomere-proximal ES promoter escapes transcription re- 
pression in a PF subpopulation. 
Discussion 
Identical promoter sequences can be transcriptionally ac- 
tive or repressed in the same nucleus, depending upon 
their chromosomal location (Nasmyth et al., 1981). Various 
forms of “silencing” have been described in a number of 
organisms (reviewed by Laurenson and Rine, 1992) and 
have been studied extensively in yeast. Telomere position 
effect is a form of silencing exerted on RNA polymerase 
II promoters in the vicinity of S. cerevisiae telomeres 
(Gottschling et al., 1990). Telomere position effect is mitoti- 
tally heritable, but reversible. In our experiments, a mitoti- 
tally heritable position effect was observed on transcrip- 
tion from three promoters inserted close to a telomere, 
at the vsg227 locus in BF cells expressing Vsg118. Our 
observations suggest that an effect similar to telomere 
position effect in yeast may be regulating transcriptional 
silencing in T. brucei. In yeast, silencing spreads only -5 
kb from the telomere (Gottschling et al., 1990). This dis- 
tance can be increased to 22 kb by altering the amount 
of transacting factors in the cell (Renauld et al., 1993). 
In T. brucei, a chromatin structure initiated at a telomere 
would have to be propagated over even longer distances 
to repress transcription from endogenous ES promoters. 
In T. brucei, pre-mRNA acquires a 5’ cap by trans- 
splicing, allowing RNA polymerase I to mediate the effi- 
cient production of mRNA. RNA polymerase I is likely to 
be responsible for transcription from rRNA, Parp, and ES 
promoters in T. brucei (reviewed by Chung et al., 1992). 
All three promoters generated similar reporter activities 
when incorporated into plasmids and transfected into PF 
cells (Zomerdijk et al., 1991). A number of stable transfor- 
mation experiments have also been carried out in PF cells. 
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These experiments show that an rRNA promoter (Zomer- 
dijk et al., 1992) and a Parp promoter (Lee, 1995) can be 
active within -5 kb of a telomere. An endogenous ES 
promoter (Rudenko et al., 1994) and ES promoters in- 
serted into tub sequences (Jefferies et al., 1993; Zomerdijk 
et al., 1993) or integrated at the RNA polymerase II largest 
subunit locus (rpo2) (urmenyi and Van der Ploeg, 1995) 
all facilitated low level reporter expression. These ES pro- 
moters generated increased reporter expression when tar- 
geted to a copy of the nontranscribed spacer of the ribo- 
somal DNA (Rudenko et al., 1994) or when integrated with 
a proximal active promoter at the rpo2 locus (Lhmenyi and 
Van der Ploeg, 1995). An ES promoterwithin tubsequence 
in BF cells did not appear to drive transcription of the re- 
porter (Jefferies et al., 1993). In our experiments, the posi- 
tion effect observed with rRNA and Parp promoters was 
developmentally regulated, but repression of the ES pro- 
moter was not relieved in PF cells. All of these observa- 
tions suggest that the ES promoter is subject to specific 
developmental control. Reactivation of the previously ex- 
pressed vsg, along with many other vsg genes, after trans- 
mission through the tsetse (Hajduk and Vickerman, 1981) 
suggests little or no preference for the ES that is activated 
when a new BF infection is initiated. Consistent with these 
observations, we and others (Rudenko et al., 1994) have 
found previously active and silent ESs to be indistinguish- 
able in PF cells. 
The presence of a telomeric DNA modification (Gom- 
mers-Ampt et al., 1993) correlates with transcription re- 
pression in BF cells, but it is unclear whether the presence 
or absence of the modification is cause or consequence 
of transcriptional silencing. Repressed and active tran- 
scription states are very efficiently inherited in BF cells, 
so the DNA modification, which may be present at all telo- 
meres except for the transcribed one, could be involved 
in marking these loci for assembly of a repressed state 
following DNA replication. The absence of detectable DNA 
modification in PF cells and continued repression of tran- 
scription from ES promoters show that this modification 
cannot be responsible for ES repression in PFcells. T. bru- 
cei chromatin components are also developmentally mod- 
ulated (Schlimme et al., 1993), which may influence tran- 
scription regulation. 
ESs can be regulated in situ in BF cells, and metacyclic 
vsg genes are also regulated in situ at the level of transcrip- 
tion (Lenardo et al., 1986). Metacyclic vsg promoters ap- 
pear to be located just upstream of the vsg, within 5 kb 
of the telomere (Alarcon et al., 1994). On the basis of our 
experiments, we can postulate that position effect in 
T. brucei could be responsible for repression of all meta- 
cyclic vsg ESs and all but one BF ES in BF cells and 
might also control vsg expression at the metacyclic stage. 
Regulation of transcription is clearly a major factor in the 
control of vsg expression in both BF and PF cells. Tran- 
scription from inserted telomeric ES promoters was acti- 
vated in a small number of cells in PF cells. We favor a 
model in which promoter-independent repression is medi- 
ated by chromatin components, whereas ES promoters, 
when on chromosomes but not within repressed chroma- 
tin, require additional factor(s) for activation. Placing pro- 
moters at different loci and at varying distances from the 
telomere will allow us to determine how transcriptionally 
repressed domains are organized in T. brucei and how 
this phenomenon relates to regulation of vsg expression. 
Experimental Procedures 
Materials 
T. brucei strain 427 BF clones 118a (MITat 1.5) and 221a (MITat 1.2) 
(Cross, 1975; Johnson and Cross, 1979) were cultured in HMI-9 at 
37% (Hirumi and Hirumi, 1994). BF cells were differentiated to PF 
ceils by transferring 1 x lo7 cells into DTM with 10 mM glycerol, 5.5 
mM proline, 15% FBS, and 3 mM citric acid cycle intermediates at 
27% (Overath et al., 1986). PF cultures were established for at least 
2 weeks prior to analysis. G418 was from GIBCO BRL, and phleomycin 
was from CayLa. 
Plasmid Constructions 
Splice acceptor and polyadenylation signals (Hug et al., 1993) were 
placed either side of the S. hindustanus b/e gene (Drocourt et al., 
1990). The act splice acceptor was a Smal-Hindlll fragment and was 
inserted at the Hpal site in pUT56 (CayLa). The act polyadenylation 
signal was a BamHI-Pstl fragment that was subsequently inserted at 
the Stul site in the resulting construct. A 519 bp Hindlll-BamHI frag- 
ment containing the rRNA promoter (White et al., 1986) was placed 
downstream of the b/e cassette at the Notl site. The entire Ndel-Sacll 
cassette was then inserted at a Smal site in pBYANA5’(V. B. Carruth- 
ers and G. A. M. C., unpublished data) to generate a cassette cbn- 
taining an rRNA promoter flanked by a selectable marker upstream 
(b/e) and downstream (neo). 
The vsg227 targeting plasmid was made from pBYANA5’by remov- 
ing a Sacl-Clal fragment. The entire b/e-rRNA promoter-neo (bRn) 
Clal-BstEll cassette was then inserted at an EcoRl site in the vsg227 
target sequence to generate pbRn. To replace the rRNA promoter with 
T. brucei Parp and ES promoters, we digested pbRn with Sfil and then 
partially digested pbRn with EcoRI. The Parp (locus A) promoter was 
on a 390 bp Apal-Smal fragment from pT1 I-bs (Patnaik et al., 1993), 
and the ES promoter was on a 315 bp Hpal-Sall fragment from 
pRKB(+) (Zomerdijk et al., 1991). Insertion of these promoters gener- 
ated pbPn and pbEn, respectively. 
Transformation and Cloning of BF T. brucei 
Plasmid DNA for transfection was prepared using anion exchange 
columns (Qiagen Incorporated). Plasmids were digested with Xhol- 
Kpnl prior to electroporation. BF cells were transformed as previously 
described (Carruthers et al., 1993). G418 (1 Nglml) was added to the 
culture 16 hr afler electroporation. Cloned cell lines were derived from 
drug-resistant cultures as described previously (Carruthers and Cross, 
1992). Cultures were subsequently grown in the absence of drug, un- 
less otherwise stated. 
RNA and DNA Analysis 
Southern blot analysis indicated that a single copy of each cassette had 
integrated at the intended position in all of the cloned transformants 
described. Genomic DNA was isolated as described previously 
(Hartree and Bellofatto, 1995). RNA was isolated using RNAzol B (Tel- 
Test Incorporated). Southern and Northern blot analyses were carried 
out according to standard protocols (Sambrook et al., 1989), and all 
posthybridization washes were at 65’C in 0.2 x SSC and 0.2% SDS. 
Hybridization signals were quantitated using a phosphorimager and 
lmagequant software (Molecular Dynamics). Pstl digests were with a 
IO-fold excess of enzyme to ensure maximum digestion of potentially 
modified DNA (Bernards et al., 1984b; Pays et al., 1984). 
Protein Analysis 
Protein concentrations were determined to be similar on Coomassie- 
stained gels, and Western blot analysis was carried out according to 
standard protocols (Sambrook et al., 1989). For indirect immunofluo- 
rescence, cells were fixed in 1% (v/v) formaldehyde at 4OC for at least 
24 hr. After washing twice in PBS and once in 1% (w/v) BSA, cell 
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suspensions were spread on multitest slides (ICN Biomedicals Incor- 
porated) and dried overnight at 37%. All subsequent washes and 
reagents were in PBS at room temperature. FBS was added to each 
well for 5 min followed by primary antibody for 45 min and two 10 min 
washes and secondary antibody for 45 min and two more washes. 
Antibodies were applied at 2.5% (v/v) in 25% (v/v) FBS in a humidified 
chamber, and Hoechst 33258 (Pierce) was applied with the primary 
antibody at 50 nglml. For Neo detection, slides were soaked in 0.5% 
(v/v) Triton X-l 00 (Sigma) for 20 min prior to blocking with FBS. Slides 
were dried and mounted in Aquamount (Polysciences Incorporated). 
Cells were observed and photographed using a Nikon Optiphot micro- 
scope with fluorescence optics. 
Primary antibodies were rabbit antiserum to the Ble protein (CayLa), 
rabbit anti-NPT-II (5 Prime-3 Prime Incorporated), rabbit antiserum to 
Vsgl18, rabbit antiserum to Vsg221, and mouse anti-Parp 348/415 
(Richardson et al., 1988). For Western blot analysis, horseradish per- 
oxidase-conjugated anti-rabbit and anti-mouse secondary antibodies 
(Amersham) were visualized using enhanced chemiluminescence 
(ECL) reagents (Amersham). Secondary fluorescent antibodies were 
FITC- or rhodamine-conjugated goat anti-rabbit (Sigma). 
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